Advice
in the absence of a submission from the holder of the marketing authorisation
bromfenac (Yellox ®) eye drops are not recommended for use within NHS Scotland.
Indication: treatment of postoperative ocular inflammation following cataract extraction in adults.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice38KB (PDF)
Medicine details
- Medicine name:
- bromfenac (Yellox)
- SMC ID:
- 740/11
- Indication:
- Treatment of postoperative ocular inflammation following cataract extraction in adults.
- Pharmaceutical company
- Bausch and Lomb GmbH
- BNF chapter
- Eye
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 10 October 2011